Relief Therapeutics Holding Stock Today
| RLFTF Stock | USD 3.90 0.06 1.52% |
Performance0 of 100
| Odds Of DistressOver 56
|
Relief Therapeutics is trading at 3.90 as of the 31st of January 2025. This is a 1.52% down since the beginning of the trading day. The stock's lowest day price was 3.8. Relief Therapeutics has over 56 % chance of experiencing financial distress in the next 2 years of operation and has generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 1st of January 2025 and ending today, the 31st of January 2025. Click here to learn more.
Relief Therapeutics Holding AG, a biopharmaceutical company, provides patients with therapeutic relief from serious diseases with high unmet medical need in Switzerland, rest of Europe, North America, and internationally. The company was founded in 2013 and is based in Geneva, Switzerland. The company has 4.39 B outstanding shares. More on Relief Therapeutics Holding
Moving together with Relief OTC Stock
| 0.65 | NVO | Novo Nordisk AS Earnings Call This Week | PairCorr |
| 0.64 | NONOF | Novo Nordisk AS Earnings Call This Week | PairCorr |
| 0.7 | VRTX | Vertex Pharmaceuticals Earnings Call This Week | PairCorr |
| 0.85 | CSLLY | CSL | PairCorr |
| 0.75 | CMXHF | CSL Limited | PairCorr |
| 0.83 | REGN | Regeneron Pharmaceuticals Earnings Call Today | PairCorr |
Moving against Relief OTC Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Relief OTC Stock Highlights
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Relief Therapeutics Holding [RLFTF] is traded as part of a regulated electronic over-the-counter service offered by the NASD. The company currently falls under 'Small-Cap' category with a current market capitalization of 120.99 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Relief Therapeutics's market, we take the total number of its shares issued and multiply it by Relief Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Relief Therapeutics classifies itself under Healthcare sector and is part of Biotechnology industry. The entity has 4.39 B outstanding shares.
Relief Therapeutics Holding has accumulated about 29.87 M in cash with (35.72 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Check Relief Therapeutics Probability Of Bankruptcy
Ownership AllocationRelief Therapeutics owns a total of 4.39 Billion outstanding shares. Relief Therapeutics holds 3.68 pct. of its outstanding shares held by insiders and 22.16 pct. owned by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Relief Ownership Details
Relief Therapeutics Risk Profiles
| Mean Deviation | 3.87 | |||
| Standard Deviation | 5.38 | |||
| Variance | 28.92 | |||
| Risk Adjusted Performance | (0.11) |
Relief Stock Against Markets
Picking the right benchmark for Relief Therapeutics otc stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Relief Therapeutics otc stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Relief Therapeutics is critical whether you are bullish or bearish towards Relief Therapeutics Holding at a given time. Please also check how Relief Therapeutics' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Relief Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Efficient Frontier Now
Efficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market. |
| All Next | Launch Module |
Relief Therapeutics Corporate Management
Elected by the shareholders, the Relief Therapeutics' board of directors comprises two types of representatives: Relief Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Relief. The board's role is to monitor Relief Therapeutics' management team and ensure that shareholders' interests are well served. Relief Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Relief Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jeremy CPA | CFO Officer | Profile | |
| David McCullough | Sr Access | Profile | |
| DPhil MBA | Chief Officer | Profile | |
| Jeremy Meinen | Chief Admin | Profile | |
| Dorian Bevec | Chief Lifescience | Profile | |
| Drew CroninFine | Exec Marketing | Profile | |
| Christopher Wick | Sr Sales | Profile |
Other Information on Investing in Relief OTC Stock
Relief Therapeutics financial ratios help investors to determine whether Relief OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Relief with respect to the benefits of owning Relief Therapeutics security.